BACKGROUND: Evidence suggests depression increases hospital readmission risk. OBJECTIVE: Determine whether depressive symptoms are associated with unplanned readmission within 30 days of discharge of general medical patients. DESIGN: Secondary analysis of the Project Re-Engineered Discharge (RED) randomized controlled trials. SETTING: Urban academic safety-net hospital. PATIENTS: A total of 1418 hospitalized adult English-speaking patients. INTERVENTION: The 9-Item Patient Health Questionnaire (PHQ-9) was used to screen patients for depressive symptoms. MEASUREMENTS: Hospital readmission within 30 days of discharge. Poisson regression was used to control for confounding variables. RESULTS: There were 225 (16%) patients who screened positive for mild depressive symptoms (5 ≤PHQ-9 ≤ 9) and 336 (24%) for moderate or severe depressive symptoms (PHQ-9 ≥ 10). After controlling for confounders, a higher rate of readmission was observed in subjects with mild depressive symptoms compared to subjects with PHQ-9 <5, incidence rate ratio (IRR) 1.49 (95% confidence interval [CI]: 1.11-2.00). The adjusted IRR of readmission for those with moderate-to-severe symptoms was 1.96 (95% CI: 1.51-2.49) compared to those with no depression. CONCLUSIONS: Screening positive for mild and moderate-to-severe depressive symptoms during a hospitalization on a general medical service is associated with an increased dose-dependent readmission rate within 30 days of discharge in an urban, academic, safety-net hospital. Further research is needed to determine whether treatments targeting the reduction of depressive symptoms reduce the risk of readmission.
RCT Entities:
BACKGROUND: Evidence suggests depression increases hospital readmission risk. OBJECTIVE: Determine whether depressive symptoms are associated with unplanned readmission within 30 days of discharge of general medical patients. DESIGN: Secondary analysis of the Project Re-Engineered Discharge (RED) randomized controlled trials. SETTING: Urban academic safety-net hospital. PATIENTS: A total of 1418 hospitalized adult English-speaking patients. INTERVENTION: The 9-Item Patient Health Questionnaire (PHQ-9) was used to screen patients for depressive symptoms. MEASUREMENTS: Hospital readmission within 30 days of discharge. Poisson regression was used to control for confounding variables. RESULTS: There were 225 (16%) patients who screened positive for mild depressive symptoms (5 ≤PHQ-9 ≤ 9) and 336 (24%) for moderate or severe depressive symptoms (PHQ-9 ≥ 10). After controlling for confounders, a higher rate of readmission was observed in subjects with mild depressive symptoms compared to subjects with PHQ-9 <5, incidence rate ratio (IRR) 1.49 (95% confidence interval [CI]: 1.11-2.00). The adjusted IRR of readmission for those with moderate-to-severe symptoms was 1.96 (95% CI: 1.51-2.49) compared to those with no depression. CONCLUSIONS: Screening positive for mild and moderate-to-severe depressive symptoms during a hospitalization on a general medical service is associated with an increased dose-dependent readmission rate within 30 days of discharge in an urban, academic, safety-net hospital. Further research is needed to determine whether treatments targeting the reduction of depressive symptoms reduce the risk of readmission.
Authors: Heidi L Wald; Luci K Leykum; Melissa L P Mattison; Eduard E Vasilevskis; David O Meltzer Journal: J Hosp Med Date: 2015-04-16 Impact factor: 2.960
Authors: Kathryn H Bowles; Jesse Chittams; Eric Heil; Maxim Topaz; Kathy Rickard; Mrinal Bhasker; Matt Tanzer; Maryam Behta; Alexandra L Hanlon Journal: Res Nurs Health Date: 2015-01-25 Impact factor: 2.228
Authors: Suzanne E Mitchell; Matthew Reichert; Jessica Martin Howard; Katherine Krizman; Alexa Bragg; Molly Huffaker; Kimberly Parker; Mary Cawley; Hannah Webb Roberts; Yena Sung; Jennifer Brown; Larry Culpepper; Howard J Cabral; Brian W Jack Journal: Ann Fam Med Date: 2022 May-Jun Impact factor: 5.707
Authors: Stephanie Doupnik; Jonathan Rodean; Bonnie T Zima; Tumaini R Coker; Diana Worsley; Kris P Rehm; James C Gay; Matt Hall; Steve Marcus Journal: J Hosp Med Date: 2018-11 Impact factor: 2.960
Authors: Suzanne E Mitchell; Jessica M Martin; Katherine Krizman; Ekaterina Sadikova; Larry Culpepper; Sabrina K Stewart; Jennifer Rose Brown; Brian W Jack Journal: Contemp Clin Trials Date: 2015-09-03 Impact factor: 2.226